| Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 X Wu, ZY Yang, Y Li, CM Hogerkorp, WR Schief, MS Seaman, T Zhou, ... Science 329 (5993), 856-861, 2010 | 2017 | 2010 |
| Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals L Ni, F Ye, ML Cheng, Y Feng, YQ Deng, H Zhao, P Wei, J Ge, M Gou, ... Immunity 52 (6), 971-977. e3, 2020 | 1235 | 2020 |
| Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface J Huang, BH Kang, M Pancera, JH Lee, T Tong, Y Feng, H Imamichi, ... Nature 515 (7525), 138-142, 2014 | 505 | 2014 |
| Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01 Y Li, S O'Dell, LM Walker, X Wu, J Guenaga, Y Feng, SD Schmidt, ... Journal of virology 85 (17), 8954-8967, 2011 | 282 | 2011 |
| Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design SK Sharma, N de Val, S Bale, J Guenaga, K Tran, Y Feng, V Dubrovskaya, ... Cell reports 11 (4), 539-550, 2015 | 238 | 2015 |
| PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4 E Falkowska, A Ramos, Y Feng, T Zhou, S Moquin, LM Walker, X Wu, ... Journal of virology 86 (8), 4394-4403, 2012 | 144 | 2012 |
| Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates C Sundling, MNE Forsell, S O'Dell, Y Feng, B Chakrabarti, SS Rao, K Loré, ... Journal of Experimental Medicine 207 (9), 2003-2017, 2010 | 129 | 2010 |
| High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site C Sundling, Y Li, N Huynh, C Poulsen, R Wilson, S O’Dell, Y Feng, ... Science translational medicine 4 (142), 142ra96-142ra96, 2012 | 127 | 2012 |
| Vaccination with glycan-modified HIV NFL envelope trimer-liposomes elicits broadly neutralizing antibodies to multiple sites of vulnerability V Dubrovskaya, K Tran, G Ozorowski, J Guenaga, R Wilson, S Bale, ... Immunity 51 (5), 915-929. e7, 2019 | 121 | 2019 |
| Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties J Guenaga, N de Val, K Tran, Y Feng, K Satchwell, AB Ward, RT Wyatt PLoS pathogens 11 (1), e1004570, 2015 | 111 | 2015 |
| Thermostability of well-ordered HIV spikes correlates with the elicitation of autologous tier 2 neutralizing antibodies Y Feng, K Tran, S Bale, S Kumar, J Guenaga, R Wilson, N de Val, ... PLoS pathogens 12 (8), e1005767, 2016 | 86 | 2016 |
| Virus-like particles identify an HIV V1V2 apex-binding neutralizing antibody that lacks a protruding loop EM Cale, J Gorman, NA Radakovich, ET Crooks, K Osawa, T Tong, J Li, ... Immunity 46 (5), 777-791. e10, 2017 | 84 | 2017 |
| Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates BK Chakrabarti, Y Feng, SK Sharma, K McKee, GB Karlsson Hedestam, ... Journal of virology 87 (24), 13239-13251, 2013 | 77 | 2013 |
| Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site Y Feng, K McKee, K Tran, S O'Dell, SD Schmidt, A Phogat, MN Forsell, ... Journal of Biological Chemistry 287 (8), 5673-5686, 2012 | 61 | 2012 |
| Influence of novel CD4 binding-defective HIV-1 envelope glycoprotein immunogens on neutralizing antibody and T-cell responses in nonhuman primates I Douagi, MNE Forsell, C Sundling, S O'Dell, Y Feng, P Dosenovic, Y Li, ... Journal of virology 84 (4), 1683-1695, 2010 | 53 | 2010 |
| Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response V Dubrovskaya, J Guenaga, N de Val, R Wilson, Y Feng, A Movsesyan, ... PLoS pathogens 13 (9), e1006614, 2017 | 48 | 2017 |
| Characterization of anti-viral immunity in recovered individuals infected by SARS-CoV-2 L Ni, F Ye, ML Chen, Y Feng, YQ Deng, H Zhao, P Wei, J Ge, X Li, L Sun, ... MedRxiv, 2020.03. 17.20036640, 2020 | 43 | 2020 |
| Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients L Ni, ML Cheng, Y Feng, H Zhao, J Liu, F Ye, Q Ye, G Zhu, X Li, P Wang, ... Frontiers in immunology 12, 603563, 2021 | 41 | 2021 |
| Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy S Hong, Q Yuan, H Xia, G Zhu, Y Feng, Q Wang, Z Zhang, W He, J Lu, ... Protein & Cell 10 (11), 840-845, 2019 | 40 | 2019 |
| Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization GE Phad, N Vázquez Bernat, Y Feng, J Ingale, PA Martinez Murillo, ... The Journal of Immunology 194 (12), 5903-5914, 2015 | 34 | 2015 |
